Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mycobacterium tuberculosis antigen presentation is a complex process involving macrophages and dendritic cells that present mycobacterial antigens via MHC class I and II pathways to T cells. M. tuberculosis actively modulates this process to evade immune detection by inhibiting MHC expression, disrupting antigen processing, manipulating the phagosomal environment, and utilizing specialized secretion systems like ESX-1 to control antigen access to the presentation pathways. Secreted antigens like ESAT-6, Ag85B, and CFP-10 are immunodominant and serve as key vaccine targets. Understanding these mechanisms is crucial for developing effective vaccines that can overcome the bacterium's evasion strategies.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterium tuberculosis Antigen Presentation (N/A).